Tiny Northwest Biotherapeutics aims to dominate brain cancer

February 26, 2014 3:15 PM

44 0

Tiny Northwest Biotherapeutics aims to dominate brain cancer

NEW YORK (Reuters) - Ten years ago, cash-strapped biotechnology company Northwest Biotherapeutics Inc was down to three employees and one week from closing its doors when a financial backer came forward at the annual JP Morgan Healthcare Conference.

By 2007, that backer, Linda Powers, had become chairman of the Maryland-based company. A venture capitalist, Powers remains one of its largest shareholders and has invested more than $20 million in the company and its experimental drugs for brain cancer and inoperable tumors.

Read more

To category page

Loading...